Integrity Implant System Post Market Clinical Follow-Up Study
Post Market Confirmatory Interventional Clinical Study of the Integrity Implant System Used for Rotator Cuff Tear Augmentation
1 other identifier
interventional
150
1 country
6
Brief Summary
The study design is a prospective, multi-center, single-arm, non-randomized post market clinical follow-up study to confirm the performance, safety and clinical benefit of the Integrity Implant System when used for rotator cuff tear augmentation (with or without repair).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2024
CompletedFirst Posted
Study publicly available on registry
December 19, 2024
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
November 13, 2025
November 1, 2025
2.3 years
December 15, 2024
November 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Re-tear rate after rotator cuff augmentation
Assessed by MRI evaluation at 12 months post-operatively defined using Sugaya classification system.
12 months postoperatively
Secondary Outcomes (4)
The American Shoulder and Elbow Surgeons (ASES) Score
Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month Post-operatively
Constant-Murley Score (CMS)
Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month post-operatively
EQ-5D-5L (EuroQol)
Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month post-operatively
The Single Assessment Numeric Evaluation (SANE) Score
Screening/Pre-Op, 6 weeks, 6-month, 12-month and 24-month post-operatively
Study Arms (1)
Integrity Implant System
OTHERInterventions
Integrity Implant System used for Rotator Cuff Repair
Eligibility Criteria
You may not qualify if:
- Medical condition that in the PI's opinion would place the subject at risk or interfere with the study
- Vulnerable population (prisoners, minors, pregnant women, mentally ill persons and the elderly or any person under any undue pressure from others to participate in the study)
- Pregnant, breastfeeding, or plans to become pregnant during the study
- History of poor compliance with medical treatment of any kind
- Deemed contraindicated for MRI by the PI
- Previous rotator cuff surgery (any type) on the index shoulder
- Current instability of the index shoulder
- Rotator cuff tendon tear is a Massive Cofield Classified Full-Thickness Tear (tear length \>5cm)
- Chondromalacia of index shoulder ≥ Grade 3
- Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3
- Insulin dependent Type I Diabetes
- History of heavy smoking (≥ 1 pack per day) within last 6-months
- History of auto-immune or immunodeficiency disorders
- Currently taking immunosuppression medication for other diseases (e.g., transplants or other inflammatory diseases)
- Oral steroid use in the last 2-months or injectable steroid use in the last 3-months
- +12 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Foundation for Orthopaedic Research and Education
Tampa, Florida, 33607, United States
Central Indiana Orthopaedics
Fishers, Indiana, 46037, United States
Towson Orthopaedic Associates/University of Maryland St. Joseph's Medical Center
Towson, Maryland, 21204, United States
Virtua Health
Marlton, New Jersey, 08053, United States
Steadman Hawkins Clinic of the Carolinas
Greenville, South Carolina, 29615, United States
Campbell Clinic
Germantown, Tennessee, 38138, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2024
First Posted
December 19, 2024
Study Start
February 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
November 13, 2025
Record last verified: 2025-11